Literature DB >> 26376343

Exogenous DNA Loading into Extracellular Vesicles via Electroporation is Size-Dependent and Enables Limited Gene Delivery.

Tek N Lamichhane1, Rahul S Raiker1, Steven M Jay1.   

Abstract

Extracellular vesicles (EVs) hold immense promise for utilization as biotherapeutics and drug delivery vehicles due to their nature as biological nanoparticles that facilitate intercellular molecular transport. Specifically, EVs have been identified as natural carriers of nucleic acids, sparking interest in their use for gene therapy and RNA interference applications. So far, small RNAs (siRNA and miRNA) have been successfully loaded into EVs for a variety of delivery applications, but the potential use of EVs for DNA delivery has scarcely been explored. Here, we report that exogenous linear DNA can be associated with EVs via electroporation in quantities sufficient to yield an average of hundreds of DNA molecules per vesicle. We determined that loading efficiency and capacity of DNA in EVs is dependent on DNA size, with linear DNA molecules less than 1000 bp in length being more efficiently associated with EVs compared to larger linear DNAs and plasmid DNAs using this approach. We further showed that EV size is also determinant with regard to DNA loading, as larger microvesicles encapsulated more linear and plasmid DNA than smaller, exosome-like EVs. Additionally, we confirmed the ability of EVs to transfer foreign DNA loaded via electroporation into recipient cells, although functional gene delivery was not observed. These results establish critical parameters that inform the potential use of EVs for gene therapy and, in agreement with other recent results, suggest that substantial barriers must be overcome to establish EVs as broadly applicable DNA delivery vehicles.

Entities:  

Keywords:  DNA delivery; electroporation; exosomes; extracellular vesicles (EVs); gene therapy; microvesicles

Mesh:

Substances:

Year:  2015        PMID: 26376343      PMCID: PMC4826735          DOI: 10.1021/acs.molpharmaceut.5b00364

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  47 in total

1.  Electroporation and electrophoretic DNA transfer into cells. The effect of DNA interaction with electropores.

Authors:  S I Sukharev; V A Klenchin; S M Serov; L V Chernomordik
Journal:  Biophys J       Date:  1992-11       Impact factor: 4.033

2.  Cancer regression in patients after transfer of genetically engineered lymphocytes.

Authors:  Richard A Morgan; Mark E Dudley; John R Wunderlich; Marybeth S Hughes; James C Yang; Richard M Sherry; Richard E Royal; Suzanne L Topalian; Udai S Kammula; Nicholas P Restifo; Zhili Zheng; Azam Nahvi; Christiaan R de Vries; Linda J Rogers-Freezer; Sharon A Mavroukakis; Steven A Rosenberg
Journal:  Science       Date:  2006-08-31       Impact factor: 47.728

3.  Differential fates of biomolecules delivered to target cells via extracellular vesicles.

Authors:  Masamitsu Kanada; Michael H Bachmann; Jonathan W Hardy; Daniel Omar Frimannson; Laura Bronsart; Andrew Wang; Matthew D Sylvester; Tobi L Schmidt; Roger L Kaspar; Manish J Butte; A C Matin; Christopher H Contag
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-23       Impact factor: 11.205

4.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells.

Authors:  Hadi Valadi; Karin Ekström; Apostolos Bossios; Margareta Sjöstrand; James J Lee; Jan O Lötvall
Journal:  Nat Cell Biol       Date:  2007-05-07       Impact factor: 28.824

5.  Inhibition of hepatitis B virus replication with linear DNA sequences expressing antiviral micro-RNA shuttles.

Authors:  Saket Chattopadhyay; Abdullah Ely; Kristie Bloom; Marc S Weinberg; Patrick Arbuthnot
Journal:  Biochem Biophys Res Commun       Date:  2009-09-04       Impact factor: 3.575

6.  A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy.

Authors:  Yanhua Tian; Suping Li; Jian Song; Tianjiao Ji; Motao Zhu; Gregory J Anderson; Jingyan Wei; Guangjun Nie
Journal:  Biomaterials       Date:  2013-12-15       Impact factor: 12.479

7.  Studies on transformation of Escherichia coli with plasmids.

Authors:  D Hanahan
Journal:  J Mol Biol       Date:  1983-06-05       Impact factor: 5.469

8.  Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes.

Authors:  Jessica Wahlgren; Tanya De L Karlson; Mikael Brisslert; Forugh Vaziri Sani; Esbjörn Telemo; Per Sunnerhagen; Hadi Valadi
Journal:  Nucleic Acids Res       Date:  2012-05-22       Impact factor: 16.971

9.  Characterization of mRNA and microRNA in human mast cell-derived exosomes and their transfer to other mast cells and blood CD34 progenitor cells.

Authors:  Karin Ekström; Hadi Valadi; Margareta Sjöstrand; Carina Malmhäll; Apostolos Bossios; Maria Eldh; Jan Lötvall
Journal:  J Extracell Vesicles       Date:  2012-04-16

10.  Optimized in vivo transfer of small interfering RNA targeting dermal tissue using in vivo surface electroporation.

Authors:  Kate E Broderick; Amy Chan; Feng Lin; Xuefei Shen; Gleb Kichaev; Amir S Khan; Justin Aubin; Tracy S Zimmermann; Niranjan Y Sardesai
Journal:  Mol Ther Nucleic Acids       Date:  2012-02-14       Impact factor: 10.183

View more
  93 in total

Review 1.  Towards rationally designed biomanufacturing of therapeutic extracellular vesicles: impact of the bioproduction microenvironment.

Authors:  Divya B Patel; Marco Santoro; Louis J Born; John P Fisher; Steven M Jay
Journal:  Biotechnol Adv       Date:  2018-09-12       Impact factor: 14.227

2.  Cardiac regeneration using human-induced pluripotent stem cell-derived biomaterial-free 3D-bioprinted cardiac patch in vivo.

Authors:  Enoch Yeung; Takuma Fukunishi; Yang Bai; Djahida Bedja; Isaree Pitaktong; Gunnar Mattson; Anjana Jeyaram; Cecillia Lui; Chin Siang Ong; Takahiro Inoue; Hiroshi Matsushita; Sara Abdollahi; Steven M Jay; Narutoshi Hibino
Journal:  J Tissue Eng Regen Med       Date:  2019-09-03       Impact factor: 3.963

Review 3.  Exosomes: cell-created drug delivery systems.

Authors:  Anastasia Familtseva; Nevena Jeremic; Suresh C Tyagi
Journal:  Mol Cell Biochem       Date:  2019-05-09       Impact factor: 3.396

4.  Functional Delivery of Lipid-Conjugated siRNA by Extracellular Vesicles.

Authors:  Aisling J O'Loughlin; Imre Mäger; Olivier G de Jong; Miguel A Varela; Raymond M Schiffelers; Samir El Andaloussi; Matthew J A Wood; Pieter Vader
Journal:  Mol Ther       Date:  2017-04-06       Impact factor: 11.454

5.  Exosome-Mediated Small RNA Delivery: A Novel Therapeutic Approach for Inflammatory Lung Responses.

Authors:  Duo Zhang; Heedoo Lee; Xiaoyun Wang; Ashish Rai; Michael Groot; Yang Jin
Journal:  Mol Ther       Date:  2018-07-10       Impact factor: 11.454

6.  Plasmid Characteristics Modulate the Propensity of Gene Exchange in Bacterial Vesicles.

Authors:  Frances Tran; James Q Boedicker
Journal:  J Bacteriol       Date:  2019-03-13       Impact factor: 3.490

Review 7.  Achieving the Promise of Therapeutic Extracellular Vesicles: The Devil is in Details of Therapeutic Loading.

Authors:  Dhruvitkumar S Sutaria; Mohamed Badawi; Mitch A Phelps; Thomas D Schmittgen
Journal:  Pharm Res       Date:  2017-03-17       Impact factor: 4.200

8.  3D printed HUVECs/MSCs cocultures impact cellular interactions and angiogenesis depending on cell-cell distance.

Authors:  Charlotte Piard; Anjana Jeyaram; Yi Liu; John Caccamese; Steven M Jay; Yu Chen; John Fisher
Journal:  Biomaterials       Date:  2019-08-14       Impact factor: 12.479

Review 9.  Emerging potential of gene silencing approaches targeting anti-chondrogenic factors for cell-based cartilage repair.

Authors:  Andrea Lolli; Letizia Penolazzi; Roberto Narcisi; Gerjo J V M van Osch; Roberta Piva
Journal:  Cell Mol Life Sci       Date:  2017-04-22       Impact factor: 9.261

10.  Biomimetic nanovesicle design for cardiac tissue repair.

Authors:  Sruti Bheri; Jessica R Hoffman; Hyun-Ji Park; Michael E Davis
Journal:  Nanomedicine (Lond)       Date:  2020-08-05       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.